These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer's drug discovery. Omtri RS; Davidson MW; Arumugam B; Poduslo JF; Kandimalla KK Mol Pharm; 2012 Jul; 9(7):1887-97. PubMed ID: 22574751 [TBL] [Abstract][Full Text] [Related]
6. The exosome of adipose-derived stem cells reduces β-amyloid pathology and apoptosis of neuronal cells derived from the transgenic mouse model of Alzheimer's disease. Lee M; Ban JJ; Yang S; Im W; Kim M Brain Res; 2018 Jul; 1691():87-93. PubMed ID: 29625119 [TBL] [Abstract][Full Text] [Related]
7. Aberrant Co-localization of Synaptic Proteins Promoted by Alzheimer's Disease Amyloid-β Peptides: Protective Effect of Human Serum Albumin. Domínguez-Prieto M; Velasco A; Vega L; Tabernero A; Medina JM J Alzheimers Dis; 2017; 55(1):171-182. PubMed ID: 27662292 [TBL] [Abstract][Full Text] [Related]
8. Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ. Miners JS; Clarke P; Love S Brain Pathol; 2017 May; 27(3):305-313. PubMed ID: 27248362 [TBL] [Abstract][Full Text] [Related]
9. Iron treatment inhibits Aβ42 deposition in vivo and reduces Aβ42/Aβ40 ratio. Shen X; Liu J; Fujita Y; Liu S; Maeda T; Kikuchi K; Obara T; Takebe A; Sayama R; Takahashi T; Matsue A; Sera K; Michikawa M; Komano H; Zou K Biochem Biophys Res Commun; 2019 May; 512(4):653-658. PubMed ID: 30791980 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of CRABP1 in human neuroblastoma cells overproducing the Alzheimer-typical Abeta42 reduces their differentiation potential. Uhrig M; Brechlin P; Jahn O; Knyazev Y; Weninger A; Busia L; Honarnejad K; Otto M; Hartmann T BMC Med; 2008 Dec; 6():38. PubMed ID: 19087254 [TBL] [Abstract][Full Text] [Related]
11. Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides. Cam M; Durieu E; Bodin M; Manousopoulou A; Koslowski S; Vasylieva N; Barnych B; Hammock BD; Bohl B; Koch P; Omori C; Yamamoto K; Hata S; Suzuki T; Karg F; Gizzi P; Erakovic Haber V; Bencetic Mihaljevic V; Tavcar B; Portelius E; Pannee J; Blennow K; Zetterberg H; Garbis SD; Auvray P; Gerber H; Fraering J; Fraering PC; Meijer L J Alzheimers Dis; 2018; 62(4):1663-1681. PubMed ID: 29504531 [TBL] [Abstract][Full Text] [Related]
12. Perforin Promotes Amyloid Beta Internalisation in Neurons. Lana E; Khanbolouki M; Degavre C; Samuelsson EB; Åkesson E; Winblad B; Alici E; Lithner CU; Behbahani H Mol Neurobiol; 2017 Mar; 54(2):874-887. PubMed ID: 26780457 [TBL] [Abstract][Full Text] [Related]
13. Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood-Brain Barrier Endothelium. Wang Z; Sharda N; Omtri RS; Li L; Kandimalla KK Mol Pharmacol; 2023 Nov; 104(5):203-213. PubMed ID: 37541759 [TBL] [Abstract][Full Text] [Related]
14. The calcineurin inhibitor Sarah (Nebula) exacerbates Aβ42 phenotypes in a Drosophila model of Alzheimer's disease. Lee S; Bang SM; Hong YK; Lee JH; Jeong H; Park SH; Liu QF; Lee IS; Cho KS Dis Model Mech; 2016 Mar; 9(3):295-306. PubMed ID: 26659252 [TBL] [Abstract][Full Text] [Related]
15. The amyloid-β degradation intermediate Aβ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer's disease. Kirabali T; Rigotti S; Siccoli A; Liebsch F; Shobo A; Hock C; Nitsch RM; Multhaup G; Kulic L Acta Neuropathol Commun; 2019 Dec; 7(1):194. PubMed ID: 31796114 [TBL] [Abstract][Full Text] [Related]
16. Influence of the familial Alzheimer's disease-associated T43I mutation on the transmembrane structure and γ-secretase processing of the C99 peptide. Tang TC; Kienlen-Campard P; Hu Y; Perrin F; Opsomer R; Octave JN; Constantinescu SN; Smith SO J Biol Chem; 2019 Apr; 294(15):5854-5866. PubMed ID: 30755484 [TBL] [Abstract][Full Text] [Related]
17. Stabilization of native amyloid β-protein oligomers by Copper and Hydrogen peroxide Induced Cross-linking of Unmodified Proteins (CHICUP). Williams TL; Serpell LC; Urbanc B Biochim Biophys Acta; 2016 Mar; 1864(3):249-259. PubMed ID: 26699836 [TBL] [Abstract][Full Text] [Related]
18. Effects of specific protease inhibitors on amyloid beta-protein 42 secretion. Yamazaki T; Ihara Y Neurobiol Aging; 1998; 19(1 Suppl):S77-9. PubMed ID: 9562473 [TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils. Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812 [TBL] [Abstract][Full Text] [Related]
20. Aß40 displays amyloidogenic properties in the non-transgenic mouse brain but does not exacerbate Aß42 toxicity in Drosophila. De Mena L; Smith MA; Martin J; Dunton KL; Ceballos-Diaz C; Jansen-West KR; Cruz PE; Dillon KD; Rincon-Limas DE; Golde TE; Moore BD; Levites Y Alzheimers Res Ther; 2020 Oct; 12(1):132. PubMed ID: 33069251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]